Showing results (431-440 of 886) with videos related to

Sort By:
Pageof 89
Scandinavian Journal of Urology|April 3, 2019
Cutaneous metastases in renal cell carcinoma: a systematic review and a case reportRikard Ohlsson, Louise Geertsen, Stine Berge Stuveseth, et al.
Scandinavian Journal of Urology|October 4, 2019
Renal trauma: a 6-year retrospective review from a level 1 trauma center in DenmarkSophia Liff Maibom, Mette Lind Holm, Niklas Kahr Rasmussen, et al.
Scandinavian Journal of Urology|August 27, 2020
Histopathological re-evaluations of biopsies in prostate cancer: a nationwide observational studyB W H van Santvoort, G J L H van Leenders, L A Kiemeney, et al.
Scandinavian Journal of Urology|January 12, 2022
Anorectal dysfunction after radical cystectomy for bladder cancerFredrik Liedberg, Oskar Hagberg, Gediminas Baseckas, et al.
Scandinavian Journal of Urology|March 22, 2021
For men enrolled in active surveillance, pre-biopsy biparametric magnetic resonance imaging significantly reduces the risk of reclassification and disease progression after 1 yearKaren-Cecilie Kortenbach, Lars Boesen, Vibeke Løgager, et al.
Scandinavian Journal of Urology|July 3, 2019
Incidence, survival and mortality trends of bladder cancer in Sweden 1997-2016Per-Uno Malmström, Truls Gårdmark, Amir Sherif, et al.
Scandinavian Journal of Urology|June 18, 2019
A randomised trial comparing two protocols for transrectal prostate repeat biopsy: six lateral posterior plus six anterior cores versus a standard posterior 12-core biopsyJoakim Örtegren, Jan Tage Holmberg, Edvard Lekås, et al.
Scandinavian Journal of Urology|May 18, 2019
Introduction of prostate artery embolization (PAE) in SwedenHans Lindgren, Mats Bläckberg
Scandinavian Journal of Urology|October 21, 2021
The safety and effectiveness of mirabegron in Parkinson's disease patients with overactive bladder: a randomized controlled trialMohamad Moussa, Mohamad Abou Chakra, Baraa Dabboucy, et al.
Scandinavian Journal of Urology|September 30, 2021
Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer has no value for treatment decisions and low correlation with nodal statusS Tenninge, H Mogos, E Eriksson, et al.
Pageof 89